ESSA Pharma Inc (EPIX)
6.20
-0.05
(-0.80%)
USD |
NASDAQ |
May 20, 14:30
ESSA Pharma Accounts Receivable (Quarterly): 0.2152M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.2152M |
December 31, 2023 | 0.1806M |
September 30, 2023 | 0.1351M |
June 30, 2023 | 0.1333M |
March 31, 2023 | 0.0088M |
December 31, 2022 | 0.0146M |
September 30, 2022 | 0.0062M |
June 30, 2022 | 0.0194M |
March 31, 2022 | 0.0193M |
December 31, 2021 | 0.002M |
September 30, 2021 | 0.489M |
June 30, 2021 | 0.2311M |
March 31, 2021 | 0.2931M |
December 31, 2020 | 0.2312M |
September 30, 2020 | 0.3095M |
June 30, 2020 | 0.3486M |
March 31, 2020 | 0.3495M |
December 31, 2019 | |
September 30, 2019 | 0.3608M |
June 30, 2019 | 0.2749M |
Date | Value |
---|---|
March 31, 2019 | 0.2437M |
December 31, 2018 | 0.2476M |
September 30, 2018 | 0.2973M |
June 30, 2018 | 0.0564M |
March 31, 2018 | 0.0585M |
December 31, 2017 | 0.0238M |
September 30, 2017 | 0.0295M |
June 30, 2017 | 0.0139M |
March 31, 2017 | 0.10M |
December 31, 2016 | 4.018M |
September 30, 2016 | 0.0159M |
June 30, 2016 | 0.0303M |
March 31, 2016 | 0.0389M |
December 31, 2015 | |
September 30, 2015 | 3.850M |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | 0.0645M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.002M
Minimum
Dec 2021
0.489M
Maximum
Sep 2021
0.1906M
Average
0.2152M
Median
Mar 2024
Accounts Receivable (Quarterly) Benchmarks
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 24.09M |
Edesa Biotech Inc | 1.112M |
Lexaria Bioscience Corp | -- |
Xenon Pharmaceuticals Inc | 0.833M |